Bio Green Med Solution (BGMS) vs XTL Biopharmaceuticals (XTLB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio Green Med Solution is the larger company by market cap ($5.6 million vs $4.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BGMS | XTLB |
|---|---|---|
| Share price | $0.85 | $1.98 |
| Market cap | $5.63M | $4.87M |
| 1-day change | -0.67% | -1.98% |
| EPS (TTM) | $-5.02 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.70 | $7.44 |
| 52-week low | $0.57 | $1.98 |
| Distance from 52-week high | -87.31% | -73.39% |
| Average volume | 74.44K | 8.49K |
| Shares outstanding | 6.62M | 2.46M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BGMS vs XTLB FAQ
Which is bigger, Bio Green Med Solution or XTL Biopharmaceuticals?
Bio Green Med Solution (BGMS) is larger, with a market capitalization of $5.63M compared with $4.87M for XTL Biopharmaceuticals (XTLB).
Are Bio Green Med Solution and XTL Biopharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.